📰 Herantis Pharma News
Herantis Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Herantis Pharma. Real-time updates on events, politics, business and more.
December 8, 2023
/PRNewswire/ -- The "Lymphoedema - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.coms offering. This "Lymphoedema- Pipeline...
June 9, 2023
Herantis Pharma Plc Company release 9 June 2023 at 14:16 EEST Herantis Pharma Oyj - Managers Transactions ____________________________________________ Person subject to the notification... | June 9, 2023
April 12, 2023
Herantis Pharma has signed European Innovation Council Accelerator grant agreement Herantis Pharma Plc, Press release, 12 April 2023 at 08:00 a.m. EEST ... | April 12, 2023
February 8, 2023
Major players in the implantable drug delivery devices market are Allergan Inc, Bayer HealthCare, Medtronic Inc, Nucletron, Boston Scientific Corporation,...
October 19, 2022
/PRNewswire/ -- The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector,...
February 19, 2022
Finnish VC Innovestor has launched a 60 million euro worth of funds in the first closing which is expected to reach 90 to 120 million euros in a year. The
November 22, 2021
Dr. Burkhard Blank brings more than 25 years of industry experience and will support the ongoing PREMIER pivotal Phase III trial for lead candidate PXT3003 to treat Charcot-Marie-Tooth Disease Type 1A
August 26, 2021
Herantis Pharma Plc Company Release August 26, 2021, at 9:00 a.m. EEST/8:00 a.m. CEST Dr. Craig Cook CEO of Herantis commented: In 2021, Herantis continued to optimize its assets and shape the... | August 27, 2021
May 10, 2021
decisivemarketsinsightsMay 10, 2021 The Cyclosporine Market is expected to grow at a CAGR of 6.82% and is poised to reach US$XX Billion by 2027 as compared to US$XX Billion in 2020. The factors leading to this extraordinary growth is attributed to various Cyclosporine market dynamics discussed in the report our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions. In order to make a pre-order inqui...
February 9, 2021
HELSINKI, Feb. 9, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an innovative ...